Component | Metric | Data source | Assessment timing | Outcome |
---|---|---|---|---|
Effectiveness | Narcotic Score | PDMP | Preintervention, intervention, postintervention | Primary efficacy |
Fatal overdose | Death certificates | Preintervention, intervention, postintervention | Secondary efficacy | |
High dose (PQA) | PDMP | Preintervention, intervention, postintervention | Secondary efficacy | |
Multiple providers (PQA) | PDMP | Preintervention, intervention, postintervention | Secondary efficacy | |
Overlapping benzo (PQA) | PDMP | Preintervention, intervention, postintervention | Secondary efficacy | |
Morphine equivalents | PDMP | Preintervention, intervention, postintervention | Secondary efficacy | |
Buprenorphine uptake | PDMP | Preintervention, intervention, postintervention | Exploratory efficacy | |
# patients approached | CDS tool | Intervention | Primary implementation | |
Reach | CDS tool use | CDS tool clicks | Intervention | Primary implementation |
Implementation | Perceptions CDS barriers | Pharmacists | Pre/post intervention | Secondary implementation |
Adoption | Perceptions CDS barriers Disposition on continued CDS use | Pharmacist partner leader interviews | Pre/post intervention | Secondary implementation |
Pharmacist partner leader interviews | Pre/post intervention | Secondary implementation | ||
Maintenance | Disposition on continued CDS use | PDMP partner leader interviews | Pre/post intervention | Secondary implementation |